Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
2013 2
2014 1
2015 3
2016 1
2018 2
2020 1
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Tumor acidity: From hallmark of cancer to target of treatment.
Bogdanov A, Bogdanov A, Chubenko V, Volkov N, Moiseenko F, Moiseyenko V. Bogdanov A, et al. Among authors: chubenko v. Front Oncol. 2022 Aug 29;12:979154. doi: 10.3389/fonc.2022.979154. eCollection 2022. Front Oncol. 2022. PMID: 36106097 Free PMC article. Review.
First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.
Moiseyenko VM, Moiseyenko FV, Yanus GA, Kuligina ES, Sokolenko AP, Bizin IV, Kudriavtsev AA, Aleksakhina SN, Volkov NM, Chubenko VA, Kozyreva KS, Kramchaninov MM, Zhuravlev AS, Shelekhova KV, Pashkov DV, Ivantsov AO, Venina AR, Sokolova TN, Preobrazhenskaya EV, Mitiushkina NV, Togo AV, Iyevleva AG, Imyanitov EN. Moiseyenko VM, et al. Among authors: chubenko va. Clin Drug Investig. 2018 Jun;38(6):553-562. doi: 10.1007/s40261-018-0629-1. Clin Drug Investig. 2018. PMID: 29470838
[Gene expression analysis and its clinical use in breast tumors].
Semiglazov VF, Semiglazov VV, Moiseenko FV, Bogdanov AA, Boĭtsov VV, Viaz'min SV, Gorab DN, Chubenko VA, Brezhnev NV, Luk'ianchikova VS, Dubina MV. Semiglazov VF, et al. Among authors: chubenko va. Vopr Onkol. 2013;59(1):25-9. Vopr Onkol. 2013. PMID: 23805447 Review. Russian. No abstract available.
Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.
Moiseyenko FV, Moiseyenko VM, Aleksakhina SN, Chubenko VA, Volkov NM, Kozyreva KS, Kramchaninov MM, Zhuravlev AS, Shelekhova KV, Ivantsov AO, Venina AR, Preobrazhenskaya EV, Mitiushkina NV, Iyevleva AG, Imyanitov EN. Moiseyenko FV, et al. Among authors: chubenko va. Oncol Res Treat. 2016;39(10):605-614. doi: 10.1159/000449024. Epub 2016 Sep 15. Oncol Res Treat. 2016. PMID: 27710972 Clinical Trial.
[Therapeutic activity of gemcitabine in intracranial tumors].
Stukov AN, Filatova LV, Latipova DKh, Bespalov VG, Belyaeva OA, Kireeva GS, Vasilieva IN, Alexandrov VA, Maidin MA, Semenov AL, Vershinina SF, Markochev AB, Abduloeva NKh, Chubenko VA, Semiglazova TY. Stukov AN, et al. Among authors: chubenko va. Vopr Onkol. 2015;61(2):274-9. Vopr Onkol. 2015. PMID: 26087611 Russian.
13 results